Reghu Balakrishnan

4 weeks ago | flipboard.com | Arijit Barman |Reghu Balakrishnan

1 day agoCNN — Toxic dust on Mars would make a future mission to the red planet extremely hazardous for astronauts and require significant countermeasures, new research suggests. Substances such as silica, gypsum, perchlorates and nanophase iron oxides contained in Martian dust could have life-threatening …

1 month ago | economictimes.indiatimes.com | Reghu Balakrishnan |Ratna Bhushan

Oct 28, 2024 | economictimes.indiatimes.com | Reghu Balakrishnan

Renuka Ramnath-led Multiples Alternate Asset Management, a home-grown private equity fund, plans to sell human resources platform PeopleStrong , said people aware of the development. Multiples has hired Bengaluru boutique bank IndigoEdge to run a sale process.The deal is expected to value PeopleStrong at ₹1,300-₹1,500 crore. Multiples has sent feelers to a handful of buyout funds and domestic PE funds, offering its seven-year-old portfolio, the people said.

Sep 25, 2024 | economictimes.indiatimes.com | Viswanath Pilla |Reghu Balakrishnan

The promoters of OneSource , a TPG Growth-backed specialty pharma contract development and manufacturing organisation ( CDMO ), are in discussions with a clutch of investors including White Oak Capital, Swiss fund HBM Healthcare Investments, Tybourne Capital and 360 ONE, to raise about $200 million (₹1,670 crore), said sources.OneSource (formerly Stelis Biopharma), promoted by Strides Pharma and its promoter Arun Kumar, got demerged from Strides Pharma, and renamed as OneSource last year.

Aug 27, 2024 | economictimes.indiatimes.com | Reena Zachariah |Reghu Balakrishnan

Canadian billionaire Prem Watsa's Fairfax Group and Bain Capital are vying for a buyout of Vadodara-based active pharmaceuticals ingredient ( API ) maker Farmson Basic Drugs in a deal valuing the company at ₹4,000 crore. "Due diligence has been done by both the private equity firms. The final bids are expected shortly," said a person close to the development.Farmson, founded in 1969 by KK Vithani, is among the largest makers of API paracetamol globally.